We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Showcases Innovative FIA and Hematology Solutions

By LabMedica International staff writers
Posted on 24 Jul 2023

HUMAN Diagnostics (Wiesbaden, Germany), a leading global provider of in-vitro diagnostic solutions, is participating in the 2023 AACC Clinical Lab Expo taking place from July 25th to 27th in Anaheim, CA, USA. More...

As a prominent exhibitor, HUMAN is located at Booth #921, where the company is showcasing its cutting-edge products and engaging with industry professionals, researchers, and healthcare experts. The company's presence at the expo reaffirms its commitment to delivering high-quality diagnostic solutions that contribute to advancing patient care and laboratory excellence.

Among the products being featured at the exhibition is the HumaCount 5D CRP, an innovative hematology analyzer that provides rapid and precise measurement of C-reactive protein (CRP), a crucial biomarker for inflammation assessment. With its advanced technology and user-friendly interface, HumaCount 5D CRP delivers reliable results and enhances laboratory efficiency. Also being highlighted at the show is the HumaNex A1c Variant which offers a breakthrough in glycated hemoglobin (A1c) testing. This fully automated assay delivers accurate results for A1c testing, even in the presence of hemoglobin variants, ensuring reliable diabetes management and monitoring.

The company is also highlighting the HumaFIA system, a high-performance fluorescence immunoassay analyzer designed for rapid and sensitive measurement of various analytes. With its versatility and efficiency, HumaFIA facilitates precise diagnostics across a wide range of applications. At the event, HUMAN's team of experts is available to discuss the company's comprehensive product portfolio, provide demonstrations, and answer any questions from attendees.

"We are excited to participate in the prestigious AACC Clinical Lab Expo and present our latest advancements in diagnostic solutions," said Thomas Roesser, Vice President International Sales. "At HUMAN, we are dedicated to developing innovative products that empower healthcare professionals to make informed decisions and improve patient outcomes."

Related Links:
HUMAN Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.